![The logo of Croatia's pharmaceutical company Pliva owned by Teva Pharmaceutical Industries is seen in front of the company's building in Zagreb March 18, 2010. Pliva was Croatia's biggest drugs firm in The logo of Croatia's pharmaceutical company Pliva owned by Teva Pharmaceutical Industries is seen in front of the company's building in Zagreb March 18, 2010. Pliva was Croatia's biggest drugs firm in](https://c8.alamy.com/compfr/2e74ayw/the-logo-of-croatias-pharmaceutical-company-pliva-owned-by-teva-pharmaceutical-industries-is-seen-in-front-of-the-companys-building-in-zagreb-march-18-2010-pliva-was-croatias-biggest-drugs-firm-in-the-1990s-and-traded-on-the-london-stock-exchange-in-the-last-decade-it-has-switched-to-generics-and-was-bought-by-barr-pharmaceuticals-which-was-then-acquired-by-israels-teva-the-worlds-biggest-generics-producer-reuters-nikola-solic-croatia-tags-business-health-2e74ayw.jpg)
The logo of Croatia's pharmaceutical company Pliva owned by Teva Pharmaceutical Industries is seen in front of the company's building in Zagreb March 18, 2010. Pliva was Croatia's biggest drugs firm in
![Teva lanzará el genérico del polémico fármaco de Mylan que multiplicó por seis su precio - eleconomistaamerica.cl Teva lanzará el genérico del polémico fármaco de Mylan que multiplicó por seis su precio - eleconomistaamerica.cl](https://s03.s3c.es/imag/_v0/770x420/3/e/2/mylan-epipen-clinton-reuters.png)
Teva lanzará el genérico del polémico fármaco de Mylan que multiplicó por seis su precio - eleconomistaamerica.cl
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA) Stock Price, Quote, News & History | Nasdaq
![Una bandera israelí se acerca al logotipo de Teva Tech, que forma parte de Teva Pharmaceutical Industries en Neot Hovav, al sur de Israel, el 14 de diciembre de 2017. REUTERS/Amir Cohen Una bandera israelí se acerca al logotipo de Teva Tech, que forma parte de Teva Pharmaceutical Industries en Neot Hovav, al sur de Israel, el 14 de diciembre de 2017. REUTERS/Amir Cohen](https://l450v.alamy.com/450ves/2cpp44n/una-bandera-israeli-se-acerca-al-logotipo-de-teva-tech-una-parte-de-teva-pharmaceutical-industries-en-la-entrada-de-las-instalaciones-de-neot-hovav-al-sur-de-israel-el-14-de-diciembre-de-2017-reuters-amir-cohen-2cpp44n.jpg)
Una bandera israelí se acerca al logotipo de Teva Tech, que forma parte de Teva Pharmaceutical Industries en Neot Hovav, al sur de Israel, el 14 de diciembre de 2017. REUTERS/Amir Cohen
![Teva chief executive Shlomo Yanai speaks during a tour at the company's new distribution centre in the central Israeli town of Shoham March 1, 2011. Teva Pharmaceutical Industries, the world's largest generics Teva chief executive Shlomo Yanai speaks during a tour at the company's new distribution centre in the central Israeli town of Shoham March 1, 2011. Teva Pharmaceutical Industries, the world's largest generics](https://c8.alamy.com/compfr/2cy6fb7/teva-chief-executive-shlomo-yanai-speaks-during-a-tour-at-the-companys-new-distribution-centre-in-the-central-israeli-town-of-shoham-march-1-2011-teva-pharmaceutical-industries-the-worlds-largest-generics-drugmaker-said-on-tuesday-it-stands-to-benefit-from-the-obama-administrations-healthcare-reform-and-other-plans-aimed-at-getting-cheaper-medicines-to-the-u-s-market-reuters-ronen-zvulun-israel-tags-business-health-2cy6fb7.jpg)
Teva chief executive Shlomo Yanai speaks during a tour at the company's new distribution centre in the central Israeli town of Shoham March 1, 2011. Teva Pharmaceutical Industries, the world's largest generics
![Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. puts on earphones prior to a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. puts on earphones prior to a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for](https://c8.alamy.com/compes/2d1c1a2/shloma-yanai-ceo-of-teva-pharmaceutical-industries-ltd-puts-on-earphones-prior-to-a-news-conference-in-cologne-march-18-2010-teva-pharmaceutical-on-thursday-bought-german-generic-pharma-maker-ratiopharm-for-3625-billion-euros-reuters-wolfgang-rattay-germany-tags-business-2d1c1a2.jpg)
Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. puts on earphones prior to a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for
![Teva Chairman Phillip Frost (C) stands with outgoing CEO Shlomo Yanai (R) and incoming CEO Jeremy Levin during a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the world's Teva Chairman Phillip Frost (C) stands with outgoing CEO Shlomo Yanai (R) and incoming CEO Jeremy Levin during a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the world's](https://c8.alamy.com/compes/2cwn2w4/teva-chairman-phillip-frost-c-stands-with-outgoing-ceo-shlomo-yanai-r-and-incoming-ceo-jeremy-levin-during-a-news-conference-in-tel-aviv-january-2-2012-teva-pharmaceutical-industries-the-worlds-largest-generics-drugmaker-said-on-monday-that-yanai-would-step-down-as-president-and-chief-executive-officer-in-may-yanai-will-be-replaced-by-levin-a-former-senior-executive-at-bristol-myers-squibb-teva-said-in-a-statement-reuters-nir-elias-israel-tags-business-drugs-society-health-2cwn2w4.jpg)
Teva Chairman Phillip Frost (C) stands with outgoing CEO Shlomo Yanai (R) and incoming CEO Jeremy Levin during a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the world's
![Industria farmacéutica: un negocio de más de un billón de dólares, que engorda gracias al coronavirus | Público Industria farmacéutica: un negocio de más de un billón de dólares, que engorda gracias al coronavirus | Público](https://www.publico.es/uploads/2020/05/08/5eb5ac820102d.jpeg)
Industria farmacéutica: un negocio de más de un billón de dólares, que engorda gracias al coronavirus | Público
![Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. reacts during a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for 3.625 billion euros. Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. reacts during a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for 3.625 billion euros.](https://c8.alamy.com/compes/2d15a8g/shloma-yanai-ceo-of-teva-pharmaceutical-industries-ltd-reacts-during-a-news-conference-in-cologne-march-18-2010-teva-pharmaceutical-on-thursday-bought-german-generic-pharma-maker-ratiopharm-for-3625-billion-euros-reuters-wolfgang-rattay-germany-tags-business-headshot-2d15a8g.jpg)
Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. reacts during a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for 3.625 billion euros.
![Flags of Croatia's pharmaceutical company Pliva owned by Teva Pharmaceutical Industries are seen in front of the company's building in Zagreb March 18, 2010. Pliva was Croatia's biggest drugs firm in the Flags of Croatia's pharmaceutical company Pliva owned by Teva Pharmaceutical Industries are seen in front of the company's building in Zagreb March 18, 2010. Pliva was Croatia's biggest drugs firm in the](https://c8.alamy.com/compes/2e75rmt/flags-of-croatias-pharmaceutical-company-pliva-owned-by-teva-pharmaceutical-industries-are-seen-in-front-of-the-companys-building-in-zagreb-march-18-2010-pliva-was-croatias-biggest-drugs-firm-in-the-1990s-and-traded-on-the-london-stock-exchange-in-the-last-decade-it-has-switched-to-generics-and-was-bought-by-barr-pharmaceuticals-which-was-then-acquired-by-israels-teva-the-worlds-biggest-generics-producer-reuters-nikola-solic-croatia-tags-business-health-2e75rmt.jpg)
Flags of Croatia's pharmaceutical company Pliva owned by Teva Pharmaceutical Industries are seen in front of the company's building in Zagreb March 18, 2010. Pliva was Croatia's biggest drugs firm in the
![Pfizer, AstraZeneca, Merck, Teva y Amazon unen fuerzas para crear un laboratorio de innovación en Israel Pfizer, AstraZeneca, Merck, Teva y Amazon unen fuerzas para crear un laboratorio de innovación en Israel](https://s03.s3c.es/imag/_v0/770x420/6/5/7/490x_coronavirus-rusia-laboratorio-reuters.jpg)